新闻发布 | AG尊龙集团中文官方网站
尊龙凯时 - 人生就是搏!
AG尊龙
跳转到主要内容
搜索
Site Search
Mainland China
|
zh
Choose locations
Americas
Asia Pacific
Europe
International
Middle East & Africa
Argentina |
Español
(link is external)
Brazil |
Português
(link is external)
Canada |
English
(link is external)
Canada |
Français
(link is external)
Central America |
Español
(link is external)
Colombia |
Español
(link is external)
Mexico |
Español
(link is external)
United States |
English
(link is external)
Australia |
English
(link is external)
Bangladesh |
English
(link is external)
Hong Kong S.A.R. |
繁體中文
(link is external)
India |
English
(link is external)
Indonesia |
English
(link is external)
Japan |
日本語
(link is external)
Korea |
한국어
(link is external)
Mainland China |
中文
Malaysia |
English
(link is external)
Pakistan |
English
(link is external)
Philippines |
English
(link is external)
Singapore |
English
(link is external)
Taiwan |
繁體中文
(link is external)
Thailand |
ภาษาไทย
(link is external)
Austria |
Deutsch
(link is external)
Belgium |
Français
(link is external)
Belgium |
Nederlands
(link is external)
Bulgaria |
Български
(link is external)
Czech Republic |
Česky
(link is external)
Czech Republic |
English
(link is external)
Denmark |
Dansk
(link is external)
Estonia |
Eesti
(link is external)
Finland |
Suomalainen
(link is external)
France |
Français
(link is external)
Germany |
Deutsch
(link is external)
Greece |
Ελληνικά
(link is external)
Hungary |
Magyar
(link is external)
Ireland |
English
(link is external)
Italy |
Italiano
(link is external)
Latvia |
Latvian
(link is external)
Lithuania |
Lithuanian
(link is external)
Netherlands |
Nederlands
(link is external)
Norway |
Norsk
(link is external)
Poland |
Polski
(link is external)
Portugal |
Português
(link is external)
Romania |
Română
(link is external)
Russia |
Русский
(link is external)
Serbia |
Srpski
(link is external)
Slovakia |
Slovensky
(link is external)
Slovenia |
Slovenščina
(link is external)
Slovenia |
English
(link is external)
Spain |
Español
(link is external)
Sweden |
Svenska
(link is external)
Switzerland |
Deutsch
(link is external)
Switzerland |
Français
(link is external)
Turkey |
Türk
(link is external)
United Kingdom |
English
(link is external)
Global |
English
(link is external)
Novartis Foundation |
English
(link is external)
Egypt |
English
(link is external)
Israel |
עברית
(link is external)
Saudi Arabia |
العربية
(link is external)
South Africa |
English
(link is external)
cn
Choose locations
asia-pacific
Americas
Asia Pacific
Europe
International
Middle East & Africa
Argentina |
Español
(link is external)
Australia |
English
(link is external)
Austria |
Deutsch
(link is external)
Bangladesh |
English
(link is external)
Belgium |
Français
(link is external)
Belgium |
Nederlands
(link is external)
Brazil |
Português
(link is external)
Bulgaria |
Български
(link is external)
Canada |
English
(link is external)
Canada |
Français
(link is external)
Central America |
Español
(link is external)
Colombia |
Español
(link is external)
Czech Republic |
Česky
(link is external)
Czech Republic |
English
(link is external)
Denmark |
Dansk
(link is external)
Egypt |
English
(link is external)
Estonia |
Eesti
(link is external)
Finland |
Suomalainen
(link is external)
France |
Français
(link is external)
Germany |
Deutsch
(link is external)
Greece |
Ελληνικά
(link is external)
Hong Kong S.A.R. |
繁體中文
(link is external)
Hungary |
Magyar
(link is external)
India |
English
(link is external)
Indonesia |
English
(link is external)
Ireland |
English
(link is external)
Israel |
עברית
(link is external)
Italy |
Italiano
(link is external)
Japan |
日本語
(link is external)
Korea |
한국어
(link is external)
Latvia |
Latvian
(link is external)
Lithuania |
Lithuanian
(link is external)
Mainland China |
中文
Malaysia |
English
(link is external)
Mexico |
Español
(link is external)
Netherlands |
Nederlands
(link is external)
Norway |
Norsk
(link is external)
Global |
English
(link is external)
Novartis Foundation |
English
(link is external)
Pakistan |
English
(link is external)
Philippines |
English
(link is external)
Poland |
Polski
(link is external)
Portugal |
Português
(link is external)
Romania |
Română
(link is external)
Russia |
Русский
(link is external)
Saudi Arabia |
العربية
(link is external)
Serbia |
Srpski
(link is external)
Singapore |
English
(link is external)
Slovakia |
Slovensky
(link is external)
Slovenia |
Slovenščina
(link is external)
Slovenia |
English
(link is external)
South Africa |
English
(link is external)
Spain |
Español
(link is external)
Sweden |
Svenska
(link is external)
Switzerland |
Deutsch
(link is external)
Switzerland |
Français
(link is external)
Taiwan |
繁體中文
(link is external)
Thailand |
ภาษาไทย
(link is external)
Turkey |
Türk
(link is external)
United Kingdom |
English
(link is external)
United States |
English
(link is external)
菜单
关于AG尊龙
战略
多元、平等与包容
员工和文化
我们的价值观
我们的领导层
AG尊龙
关于AG尊龙
患者与照护者
AG尊龙对患者和照护者的承诺
疾病领域
临床试验
患者与照护者
AG尊龙在中国
概览
企业责任
AG尊龙大事记
AG尊龙中国业务
AG尊龙中国荣誉
AG尊龙在中国
环境、社会和治理
道德、风险和合规
可及性
环境可持续发展
全球健康
道德行为
环境、社会和治理
新闻中心
新闻发布
专题故事
媒体联络
新闻中心
职业发展
职位搜索
人才发展
员工福利
全球荣誉
(link is external)
职业发展
首页
页眉
AG尊龙上海园区
扎根中国,承诺中华
主页
新闻中心
新闻发布
新闻发布
Date Range
- 任意 -
In The News
Media Release
Featured News
Story
News Type Filters
Language
- 任意 -
English
French
German
开始日期
结束日期
News Archive Navigation
News Archive Navigation
全部
新闻发布
专题故事
icon
列表视图
Showing 245 results
8月 2023
Featured News
8月 15, 2023
AG尊龙完成对 Chinook Therapeutics 的收购
7月 2023
Featured News
7月 30, 2023
AG尊龙宣布收购 DTx Pharma,强化神经科学产品线和 xRNA 技术平台能力
Story
7月 28, 2023
发现
医药未来已来
6月 2023
Featured News
6月 21, 2023
AG尊龙茁乐®(奥马珠单抗)预充式注射液/在家使用制剂新适应获批,惠及慢性自发性荨麻疹患者
Featured News
6月 15, 2023
AG尊龙Iptacopan上市许可申请正式纳入优先审评程序
Featured News
6月 13, 2023
AG尊龙宣布收购Chinook Therapeutics,进一步强化创新药物战略并拓展肾脏疾病领域管线
五月 2023
Featured News
5月 20, 2023
AG尊龙瑞波西利新适应症获批,为HR+/HER2-晚期乳腺癌患者带来显著生存获益
4月 2023
Featured News
4月 27, 2023
重磅官宣:PNH首个口服单药iptacopan关键III期研究达到主要终点
Featured News
4月 13, 2023
捷恪卫®(磷酸芦可替尼片)治疗急性移植物抗宿主病适应症在华获批
Featured News
4月 11, 2023
茁乐®(奥马珠单抗)预充式注射针/在家使用制剂登陆中国,惠及过敏性哮喘患者
Featured News
4月 03, 2023
全球首个治疗儿童BRAF V600E 低级别胶质瘤的联合靶向疗法美国获批
Featured News
4月 02, 2023
可善挺®(司库奇尤单抗)强直性脊柱炎适应症获批新增300mg剂量方案
分页
‹
前一页
1
…
3
4
5
6
7
8
9
…
21
›
下一页
网站首页
AG尊龙